Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.6095
-0.0405 (-6.23%)
Jun 26, 2026, 1:44 PM EDT - Market open
Alps Group Market Cap
Alps Group has a market cap or net worth of $101.42 million as of June 26, 2026. Its market cap has increased by 53.89% in one year.
Market Cap
101.42M
Enterprise Value
101.56M
1-Year Change
53.89%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since December 23, 2021, Alps Group's market cap has decreased from $143.00M to $101.42M, a decrease of -29.07%. That is a compound annual growth rate of -7.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 101.42M | -29.89% |
| Dec 31, 2025 | 144.67M | 230.19% |
| Dec 30, 2024 | 43.81M | -50.64% |
| Dec 29, 2023 | 88.76M | -41.77% |
| Dec 30, 2022 | 152.44M | 6.93% |
| Dec 30, 2021 | 142.56M | -0.30% |
| Dec 23, 2021 | 143.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 114.31M |
| Polaryx Therapeutics | 112.91M |
| Oncolytics Biotech | 109.77M |
| Aardvark Therapeutics | 108.43M |
| Black Diamond Therapeutics | 106.87M |
| Fortress Biotech | 106.80M |
| Vivani Medical | 106.76M |
| Cue Biopharma | 105.27M |